Cargando…

Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas

OBJECTIVE: To explore the correlation of mutation landscape with clinical outcomes in patients with peripheral T-cell lymphoma (PTCL). METHODS: We retrospectively analyzed the clinicopathological and prognosis data of 53 patients with PTCL from November 2011 to December 2017. Targeted next-generatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Yingying, Ding, Ning, Mi, Lan, Shi, Yunfei, Liu, Weiping, Song, Yuqin, Shu, Shaokun, Zhu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866778/ https://www.ncbi.nlm.nih.gov/pubmed/33546774 http://dx.doi.org/10.1186/s40164-021-00200-x

Ejemplares similares

Conditional survival and hazards of death for peripheral T-cell lymphomas
por: Gao, Hongye, et al.
Publicado: (2021)

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis
por: Gao, Hongye, et al.
Publicado: (2022)

EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP
por: Li, Jiao, et al.
Publicado: (2017)

Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen
por: Yu, Hui, et al.
Publicado: (2022)

Conditional Survival and Annual Hazard Estimates of Classical Hodgkin Lymphoma
por: Nuersulitan, Reyizha, et al.
Publicado: (2021)

The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma
por: Shi, Cunzhen, et al.
Publicado: (2018)

Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
por: Hu, Yunfei, et al.
Publicado: (2014)

Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma
por: Yu, Hui, et al.
Publicado: (2021)

Genetic Landscape of Peripheral T-Cell Lymphoma
por: Hathuc, Vivian, et al.
Publicado: (2022)

The Clonal Diversity of Peripheral B Cell Receptor Immune Repertoire Impaired by Residual Malignant B Cells Predicts Treatment Efficacy in B Cell Lymphoma Patients
por: Wu, Meng, et al.
Publicado: (2022)

Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study
por: Liu, Shuo, et al.
Publicado: (2022)

The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma
por: Li, Jiao, et al.
Publicado: (2022)

Homozygous A polymorphism of the complement C1qA(276) correlates with prolonged overall survival in patients with diffuse large B cell lymphoma treated with R-CHOP
por: Jin, Xuan, et al.
Publicado: (2012)

Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era
por: Nuersulitan, Reyizha, et al.
Publicado: (2022)

The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma
por: Wang, Xing, et al.
Publicado: (2021)

Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China
por: Liu, Jiaxin, et al.
Publicado: (2023)

Relapsed anaplastic lymphoma kinase-positive large B-cell lymphoma expressed cluster of differentiation 4 and cytokeratin: An initially misdiagnosed case corrected by immunoglobulin κ locus gene rearrangement detection
por: Shi, Yunfei, et al.
Publicado: (2017)

Long-term survival benefit of anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma
por: Liu, Weiping, et al.
Publicado: (2023)

Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma
por: Zhang, Chen, et al.
Publicado: (2023)

Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas
por: Wu, Meng, et al.
Publicado: (2018)

Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma
por: Gui, Lin, et al.
Publicado: (2021)

Burden of lymphoma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016
por: Liu, Weiping, et al.
Publicado: (2019)

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
por: Liu, Yalu, et al.
Publicado: (2017)

A Comparison of Clinical Prognostic Indices in Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with a Pegylated Liposomal Doxorubicin Combination Regimen in China
por: Gao, Hongye, et al.
Publicado: (2022)

Different situations of identifying second primary malignant tumors in lymphoma patients with synchronous solid tumors
por: Gao, Hongye, et al.
Publicado: (2023)

Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
por: Ji, Meng-Meng, et al.
Publicado: (2018)

Burden of lymphoma in China, 1990−2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019
por: Liu, Weiping, et al.
Publicado: (2022)

Irreversible dual inhibitory mode: the novel Btk inhibitor PLS-123 demonstrates promising anti-tumor activity in human B-cell lymphoma
por: Ding, Ning, et al.
Publicado: (2015)

ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma
por: Liu, Yalu, et al.
Publicado: (2019)

Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation
por: Qi, Fei, et al.
Publicado: (2022)

The Role of Epigenetic Modifier Mutations in Peripheral T-Cell Lymphomas
por: Tigu, Adrian-Bogdan, et al.
Publicado: (2023)

Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma
por: Liu, Xiaoqian, et al.
Publicado: (2022)

Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma
por: Gomez, Felicia, et al.
Publicado: (2023)

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin
por: Deng, Lijuan, et al.
Publicado: (2015)

P1287: HETROMBOPAG FOR ENHANCEMENT OF PLATELET ENGRAFTMENT IN PATIENTS WITH LYMPHOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Zhao, Linjun, et al.
Publicado: (2023)

Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells
por: Ding, Ning, et al.
Publicado: (2014)

Mortality Rate of Lymphoma in China, 2013–2020
por: Liu, Weiping, et al.
Publicado: (2022)

Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma
por: He, Yizi, et al.
Publicado: (2019)

Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group
por: Liu, Weiping, et al.
Publicado: (2021)

A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma
por: Ozawa, Michael G, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_viojqjinjf3mf649e9ss0ou2dd